Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

133.45
BATS BZX Real-Time Price
As of 2:50pm ET
 +3.00 / +2.30%
Today’s Change
75.52
Today|||52-Week Range
153.15
+33.09%
Year-to-Date
The Best- and Worst-Performing Stocks of Last Decade
Jul 16 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close130.45
Today’s open130.52
Day’s range129.59 - 134.35
Volume55,418
Average volume (3 months)1,926,817
Market cap$26.7B
Dividend yield--
Data as of 2:50pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-239.66%
Earnings growth (next 5 years)+98.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book58.73

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+2.39+1.88%
ZTSZoetis Inc+0.34+0.54%
MYLMylan NV+1.08+2.83%
BAXBaxter International...+0.45+0.73%
Data as of 2:50pm ET, 07/20/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.00
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts